AGILE: a seamless phase I/IIa platform for the rapid evaluation of candidates for COVID-19 treatment: an update to the structured summary of a study protocol for a randomised platform trial letter. (2021)
Attributed to:
AGILE: Seamless Phase I/IIa Platform for the Rapid Evaluation of Candidates for COVID-19 treatment
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s13063-021-05458-4
PubMed Identifier: 34311777
Publication URI: http://europepmc.org/abstract/MED/34311777
Type: Journal Article/Review
Volume: 22
Parent Publication: Trials
Issue: 1
ISSN: 1745-6215